Everpar Advisors LLC lifted its position in Centene Co. (NYSE:CNC – Free Report) by 51.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 7,621 shares of the company’s stock after purchasing an additional 2,590 shares during the quarter. Everpar Advisors LLC’s holdings in Centene were worth $462,000 at the end of the most recent quarter.
Other institutional investors also recently added to or reduced their stakes in the company. Park Place Capital Corp grew its position in shares of Centene by 1,190.0% during the third quarter. Park Place Capital Corp now owns 387 shares of the company’s stock worth $29,000 after acquiring an additional 357 shares during the last quarter. Private Trust Co. NA increased its stake in Centene by 75.3% in the third quarter. Private Trust Co. NA now owns 773 shares of the company’s stock valued at $58,000 after purchasing an additional 332 shares during the period. True Wealth Design LLC purchased a new stake in shares of Centene in the third quarter valued at about $66,000. EverSource Wealth Advisors LLC boosted its stake in shares of Centene by 104.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,231 shares of the company’s stock worth $82,000 after buying an additional 630 shares during the period. Finally, Venturi Wealth Management LLC grew its holdings in shares of Centene by 77.3% during the third quarter. Venturi Wealth Management LLC now owns 1,163 shares of the company’s stock worth $88,000 after buying an additional 507 shares during the last quarter. Institutional investors and hedge funds own 93.63% of the company’s stock.
Analyst Ratings Changes
A number of research firms have weighed in on CNC. Sanford C. Bernstein lowered their target price on Centene from $96.00 to $88.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 30th. UBS Group upgraded shares of Centene from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $79.00 to $80.00 in a research report on Friday, December 13th. JPMorgan Chase & Co. restated an “overweight” rating and set a $75.00 price objective (down previously from $80.00) on shares of Centene in a research report on Tuesday, December 17th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $90.00 target price on shares of Centene in a report on Wednesday, December 11th. Finally, Stephens reduced their price objective on shares of Centene from $75.00 to $73.00 and set an “equal weight” rating for the company in a research report on Friday, December 13th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and ten have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $80.92.
Insider Activity
In other news, CFO Andrew Lynn Asher bought 17,200 shares of the firm’s stock in a transaction that occurred on Wednesday, November 13th. The shares were purchased at an average price of $58.14 per share, for a total transaction of $1,000,008.00. Following the completion of the transaction, the chief financial officer now owns 486,847 shares in the company, valued at $28,305,284.58. The trade was a 3.66 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director H James Dallas purchased 1,693 shares of the business’s stock in a transaction on Monday, December 16th. The stock was acquired at an average price of $59.01 per share, with a total value of $99,903.93. Following the completion of the acquisition, the director now directly owns 1,693 shares in the company, valued at $99,903.93. The trade was a ∞ increase in their position. The disclosure for this purchase can be found here. Insiders have purchased 45,010 shares of company stock worth $2,660,276 over the last three months. 0.29% of the stock is currently owned by corporate insiders.
Centene Price Performance
CNC stock opened at $62.86 on Friday. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.10 and a current ratio of 1.10. The stock’s 50 day moving average price is $60.07 and its 200 day moving average price is $67.38. The firm has a market cap of $31.74 billion, a P/E ratio of 10.91, a PEG ratio of 0.83 and a beta of 0.45. Centene Co. has a 1 year low of $55.03 and a 1 year high of $81.42.
Centene Profile
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Featured Articles
- Five stocks we like better than Centene
- 10 Best Airline Stocks to Buy
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- What Are Some of the Best Large-Cap Stocks to Buy?
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
- Transportation Stocks Investing
- Top Growth Picks: 3 Low-Cost Stocks That Could Double in Value
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Co. (NYSE:CNC – Free Report).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.